Insmed To Present at the 2025 Goldman Sachs Annual Global Healthcare Conference
BRIDGEWATER, N.J., May 28, 2025 — Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company, announced that its management will present at the 2025 Goldman Sachs Annual Global Healthcare Conference in Miami on Wednesday, June 11, 2025, at 9:20 a.m. ET.
This event will be webcast live and can be accessed through the investor relations section of the Company’s website at www.insmed.com. The webcasts will be archived for 30 days following the conclusion of the live events.
About Insmed
Insmed Incorporated is dedicated to delivering first- and best-in-class therapies to transform the lives of patients with serious diseases. The company has a diverse portfolio of approved and investigational medicines, focusing on pulmonary and inflammatory conditions. It is headquartered in Bridgewater, New Jersey, and operates offices and research locations in the United States, Europe, and Japan. Insmed has been recognized as a top employer in the biopharmaceutical industry, achieving the No. 1 spot as a Science Top Employer for four consecutive years. Visit www.insmed.com to learn more.
Contact:
Investors:
Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
[email protected]
Media:
Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
[email protected]
SOURCE: Insmed Incorporated